# US 2003/0082784 A1 · Novel peptide having osteogenetic activity and osteogenetic accelerator containing the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0082784 A1
- Document ID: US20030082784A1
- Status: Published application
- Kind: A1
- Application number: 10/233,284
- Filed: 2002-08-30
- Published: 2003-05-01
- Earliest claimed: 2001-08-31
- Assignees: Yoshihiko NISHIMURA
- Inventors: Yoshihiko Nishimura; Yoshihisa Suzuki; Masao Tanihara
- Web page: https://patentgrep.com/patent/US20030082784A1

## CPC

- C07K 14/51: Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 19/00: Drugs for skeletal disorders
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61P 19/10: for osteoporosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A peptide has at least an amino acid sequence represented by SEQ ID NO:1 and it has an osteogenetic activity.

## Claims

### Claim 1

A peptide having at least an amino acid sequence represented by SEQ ID NO:1 and having an osteogenetic activity.

### Claim 2 (depends on 1)

A peptide according to claim 1 having amino acid sequences SEQ ID NO:1 and SEQ ID No:2 combined to each other with or without intervention of 1 to 10 amino acid residues which are, the same or different, selected from Asn, Cys, Pro, Gly, Ala, Val, Leu, Ile, Ser, Thr, Glu, Asp, Lys and Tyr.

### Claim 3 (depends on 1)

A peptide according to claim 1 having amino acid sequences of SEQ ID NO:1 and SEQ ID No:3 combined to each other with or without intervention of 1 to 10 amino acid residues which are, the same or different, selected from Asn, Cys, Pro, Gly, Ala, Val, Leu, Ile, Ser, Thr, Glu, Asp, Lys and Tyr.

### Claim 4 (depends on 1, 2, 3)

A peptide according to anyone of claims 1 to 3 having amino acid sequences SEQ ID NO:1, SEQ ID No:2 and SEQ ID No:3 combined to one another with or without intervention of 1 to 10 amino acid residues which are, the same or different, selected from Asn, Cys, Pro, Gly, Ala, Val, Leu, Ile, Ser, Thr, Glu, Asp, Lys and Tyr.

### Claim 5 (depends on 1, 2, 3, 4)

A peptide according to any one of claims 1 to 4, wherein the amino acid sequence represented by SEQ ID NO:1 is located at a C terminal.

### Claim 6 (depends on 1, 2, 3, 4, 5)

A peptide according to any one of claims 1 to 5, which is one of amino acid sequences represented by SEQ ID NO: 4 to SEQ ID NO: 7, or one of amino acid sequences represented by SEQ ID NO: 4 to SEQ ID NO: 7 which has an amide group at a C terminal.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

An osteogenetic accelerator containing a peptide as set forth in any one of claims 1 to 6 as an active ingredient.

### Claim 8 (depends on 7)

An osteogenetic accelerator according to claim 7, wherein the peptide is attached to a carrier.
